AstraZeneca (AZN) Stock Insights

AZN price $169.51 -0.57 -0.34%

Ticker
AZN
Price
$169.51
Change
-0.57 -0.34%
Market cap ?
$262.89B
Sector
Healthcare
Industry
Drug Manufacturers - General

AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, renal, metabolic, and…

Fair value

AZN fair value $305.39. Price $169.51. Price is 44% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 95% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 8.74B. Growth 11.35%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 1.55B. Net debt 23.99B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare AZN

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-30—2.60—16.00B
2026-07-272.632.5015.38B15.44B
2026-04-292.582.5715.29B14.93B
2026-02-102.122.0915.50B15.44B
2025-11-062.382.2815.19B14.78B
2025-07-292.182.1814.46B14.10B
2025-04-292.482.2013.59B13.81B
2025-02-062.102.0714.89B14.23B
2024-11-122.082.0213.56B13.08B
2024-07-251.981.9212.94B12.62B
2024-04-252.061.9012.68B11.80B
2024-02-081.461.4812.02B12.08B
2023-11-090.860.8411.49B11.55B
2023-07-281.080.9911.42B11.01B
2023-04-271.161.0710.88B10.60B
2023-02-090.690.6711.21B11.25B
2022-11-100.840.7610.98B10.79B
2022-07-290.860.7810.77B10.45B
2022-04-291.900.8611.39B10.99B
2022-02-101.680.7712.01B11.16B
2021-11-121.080.639.87B11.28B
2021-07-290.900.458.22B7.59B
2021-04-301.620.757.32B6.64B
2021-02-111.081.067.41B8.94B
2020-11-050.940.986.58B6.13B
2020-07-300.960.466.28B5.75B
2020-04-291.060.476.35B5.54B
2020-02-140.481.066.66B8.25B
2019-10-240.500.486.41B5.69B
2019-07-250.740.305.82B4.46B
2019-04-260.900.425.49B5.10B
2019-02-141.580.766.42B6.16B
2018-11-080.720.455.34B6.01B
2018-07-260.700.305.16B4.30B
2018-05-180.480.565.18B6.70B
2018-02-021.300.905.78B5.35B
2017-11-091.120.556.23B6.12B
2017-07-270.880.425.05B4.81B
2017-04-271.000.765.41B4.05B
2017-02-021.220.595.58B5.40B

Dividends

Yield 1.91%. Payout ratio 47.05%. Frequency Semi-Annual.

Safety score 88/100 · Safe. Payout ratio is 47% of earnings. Dividends use a moderate share of free cash flow. Dividends were paid in 34 separate years. Yield is 1.9%, in a range that is usually sustainable.

Ex-dateDividendRecordPaymentFrequency
2026-08-07$1.062026-08-072026-09-08Semi-Annual
2026-02-20$2.172026-02-202026-03-23Semi-Annual
2025-08-08$1.032025-08-082025-09-08Semi-Annual
2025-02-21$2.132025-02-212025-03-24Semi-Annual
2024-08-09$1.002024-08-092024-09-09Semi-Annual
2024-02-22$1.972024-02-232024-03-25Semi-Annual
2023-08-10$0.932023-08-112023-09-11Semi-Annual
2023-02-23$1.972023-02-242023-03-27Semi-Annual
2022-08-11$0.932022-08-122022-09-12Semi-Annual
2022-02-24$1.972022-02-252022-03-28Semi-Annual
2021-08-12$0.902021-08-132021-09-13Semi-Annual
2021-02-25$1.942021-02-262021-03-29Semi-Annual
2020-08-13$0.912020-08-142020-09-14Semi-Annual
2020-02-27$1.882020-02-282020-03-30Semi-Annual
2019-08-08$0.872019-08-092019-09-09Semi-Annual
2019-02-28$1.902019-03-012019-03-27Semi-Annual
2018-08-09$0.902018-08-102018-09-10Semi-Annual
2018-02-15$1.902018-02-162018-03-19Semi-Annual
2017-08-09$0.902017-08-112017-09-11Semi-Annual
2017-02-15$1.902017-02-172017-03-20Semi-Annual
2016-08-10$0.902016-08-122016-09-12Semi-Annual
2016-02-17$1.902016-02-192016-03-21Semi-Annual
2015-08-12$0.902015-08-142015-09-14Semi-Annual
2015-02-18$1.902015-02-202015-03-23Semi-Annual
2014-08-13$0.902014-08-152014-09-15Semi-Annual
2014-02-19$1.902014-02-212014-03-24Special
2013-08-14$0.902013-08-162013-09-16Semi-Annual
2013-02-13$1.902013-02-152013-03-18Special
2012-08-08$0.902012-08-102012-09-10Semi-Annual
2012-02-15$1.952012-02-172012-03-19Semi-Annual
2011-08-04$0.852011-08-082011-09-12Semi-Annual
2011-02-02$1.852011-02-042011-03-14Semi-Annual
2010-08-04$0.702010-08-062010-09-13Semi-Annual
2010-02-03$1.712010-02-052010-03-15Semi-Annual
2009-08-05$0.592009-08-072009-09-14Semi-Annual
2009-02-04$1.502009-02-062009-03-16Semi-Annual
2008-08-06$0.552008-08-082008-09-15Semi-Annual
2008-02-07$1.352008-02-112008-03-17Semi-Annual
2007-08-08$0.522007-08-102007-09-17Semi-Annual
2007-02-07$1.232007-02-092007-03-19Semi-Annual
2006-08-09$0.492006-08-112006-09-18Semi-Annual
2006-02-08$0.922006-02-102006-03-20Semi-Annual
2005-08-10$0.382005-08-122005-09-19Semi-Annual
2005-02-09$0.652005-02-112005-03-21Semi-Annual
2004-08-11$0.292004-08-132004-09-20Semi-Annual
2004-02-18$0.542004-02-202004-04-06Semi-Annual
2003-08-20$0.262003-08-222003-10-06Semi-Annual
2003-02-19$0.522003-02-212003-04-07Semi-Annual
2002-08-21$0.262002-08-232002-10-07Semi-Annual
2002-02-20$0.522002-02-222002-04-08Semi-Annual
2001-08-22$0.262001-08-242001-10-05Semi-Annual
2001-02-21$0.522001-02-232001-04-09Quarterly
2000-11-14$1.07——Quarterly
2000-09-06$0.262000-09-082000-10-23Semi-Annual
2000-03-08$0.522000-03-102000-04-17Semi-Annual
1999-09-08$0.261999-09-101999-10-25Semi-Annual
1999-04-07$0.501999-04-091999-04-28Semi-Annual
1998-09-16$0.28——Semi-Annual
1998-03-18$0.51——Semi-Annual
1997-09-17$0.27——Semi-Annual
1997-03-19$0.45——Semi-Annual
1996-09-20$0.24——Semi-Annual
1996-03-22$0.25——Semi-Annual
1995-09-22$0.22——Semi-Annual
1995-03-24$0.35——Semi-Annual
1994-09-23$0.21——Semi-Annual
1994-03-18$0.31——Semi-Annual
1993-09-24$0.19——Semi-Annual

Insider trades

DateInsiderActionSharesPriceValue
2028-12-01Sharma ManiOther195$123.9824.18K
2026-10-06Sharma ManiBuy2$159.80320
2026-09-08Sharma ManiBuy1$162.60163
2026-08-08Sharma ManiBuy20$160.573.25K
2026-08-06Sharma ManiBuy2$163.34327
2026-07-06Sharma ManiBuy2$190.43381
2026-06-08Sharma ManiBuy1$179.75180
2026-05-20Sharma ManiSell11.89K$185.782.21M
2026-05-06Sharma ManiBuy1$186.28186
2026-04-07Sharma ManiBuy1$196.03196
2026-03-18Sharma ManiOther0——
2026-03-18Sharma ManiOther3.00K——
2026-03-18Sharma ManiOther31——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 1.52K, holders +152 vs prior quarter. Ownership 52.03%.

HolderSharesChangeChange %Value
EVELYN PARTNERS GROUP LTD2.24M2.24MNew41.52B
INVESTOR AB51.59M00.00%9.78B
VANGUARD CAPITAL MANAGEMENT LLC45.39M346.05K+0.77%8.47B
CAPITAL INTERNATIONAL INVESTORS34.58M183.06K+0.53%6.49B
NORGES BANK33.86M33.86MNew6.33B
CAPITAL WORLD INVESTORS30.08M1.81M+6.41%5.63B
FMR LLC28.90M-706.46K-2.39%5.42B
WELLINGTON MANAGEMENT GROUP LLP28.54M4.79M+20.15%5.36B
LEGAL & GENERAL GROUP PLC25.75M-99.73K-0.39%4.82B
JPMORGAN CHASE & CO19.20M613.90K+3.30%3.67B
VANGUARD ASSET MANAGEMENT, LTD18.71M177.60K+0.96%3.49B
PRIMECAP MANAGEMENT CO/CA/18.10M-118.53K-0.65%3.43B
BANK OF AMERICA CORP /DE/17.69M-1.37M-7.18%3.35B
PRICE T ROWE ASSOCIATES INC /MD/16.62M-2.87M-14.74%3.15B
AMUNDI16.42M1.04M+6.74%3.11B
FRANKLIN TEMPLETON INC16.51M-1.28M-7.20%3.11B
VANGUARD FIDUCIARY TRUST CO13.29M95.91K+0.73%2.48B
DEUTSCHE BANK AG\12.64M510.95K+4.21%2.40B
JUPITER TOPCO LLC11.87M11.87MNew2.22B
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN11.72M-1.22M-9.41%2.19B
FISHER ASSET MANAGEMENT, LLC11.15M300.58K+2.77%2.11B
AVIVA PLC10.90M-187.96K-1.70%2.04B
ROYAL BANK OF CANADA10.43M41.05K+0.40%1.98B
INVESCO LTD.10.18M73.26K+0.73%1.93B
ROYAL LONDON ASSET MANAGEMENT LTD10.16M-138.54K-1.35%1.93B

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

AstraZeneca (AZN) Stock Insights

AZN$169.51-0.57 -0.34%

$262.89B

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History